View in EDS HTML Full Text PDF Full Text

Long‐Term Outcomes of an Infliximab‐First Versus Vedolizumab‐First Treatment Strategy in Biologic‐Naïve Patients With Ulcerative Colitis.

Saved in:
Bibliographic Details
Title: Long‐Term Outcomes of an Infliximab‐First Versus Vedolizumab‐First Treatment Strategy in Biologic‐Naïve Patients With Ulcerative Colitis.
Authors: Haynesworth, Austin1 (AUTHOR), Yeh, Kuan‐Hung2 (AUTHOR), Lee, Han Hee1,3 (AUTHOR), Kirkpatrick, Melissa4 (AUTHOR), Boland, Brigid S.1 (AUTHOR), Syal, Gaurav1 (AUTHOR), Xu, Ronghui5 (AUTHOR), Singh, Siddharth1,2 (AUTHOR) sis040@ucsd.edu
Source: Alimentary Pharmacology & Therapeutics. Feb2025, Vol. 61 Issue 4, p693-701. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:02692813
DOI:10.1111/apt.18441